Home / Import refusals / NUV-3849644-7/20002/1

FDA Import Refusal NUV-3849644-7/20002/1 — AbbVie Inc.

AbbVie Inc. — FEI 3009751352

The FDA refused shipment NUV-3849644-7/20002/1 from AbbVie Inc. (United States) on November 3, 2025. The refused product falls under Drugs and Biologics — RISANKIZUMAB-RZAA. Cited charge: 179 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 3, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
58MCP09 RISANKIZUMAB-RZAA
Charges
179

Recent inspections

  • 1299008 (NAI Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277010 (NAI Thu Aug 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1257605 (NAI Thu Jun 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1231413 (NAI Fri Apr 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1198013 (VAI Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0768117-3/10002/1A (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-9968726-6/20003/1 (Wed Jan 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 799-9161571-9/10001/1 (Sun Dec 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8712399-1/10001/1 (Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7803787-9/10001/1 (Tue Nov 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources